We are live on
!
Find out more
VKH
Virtu KCG Holdings Portfolio holdings
AUM
$3.6B
1-Year Est. Return
17.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.83%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.61B
AUM Growth
-$449M
(-11%)
Cap. Flow
-$605M
Cap. Flow
% of AUM
-16.78%
Top 10 Holdings %
Top 10 Hldgs %
30.4%
Holding
4,266
New
919
Increased
956
Reduced
1,173
Closed
1,190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$14.3M |
| 2 |
JPMorgan Chase
JPM
|
+$14.1M |
| 3 |
Altria Group
MO
|
+$12.2M |
| 4 |
GLDW
SPDR Long Dollar Gold Trust
GLDW
|
+$11.2M |
| 5 |
Goldman Sachs
GS
|
+$8.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.3M |
| 2 |
Bank of America
BAC
|
+$13.3M |
| 3 |
Citigroup
C
|
+$12.9M |
| 4 |
ProShares Short High Yield
SJB
|
+$12.2M |
| 5 |
Microsoft
MSFT
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.25% |
| 2 | Technology | 6.44% |
| 3 | Consumer Discretionary | 6.18% |
| 4 | Healthcare | 5.48% |
| 5 | Industrials | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Celldex Therapeutics
CLDX
$2.99B
| $76K | ﹤0.01% |
1,406
-8,042
| -85% | -$419K |
|
|
KIN
2752
DELISTED
Kindred Biosciences, Inc.
KIN
| $76K | ﹤0.01% |
+10,790
| New | +$67.6K |
|
2753
Codexis
CDXS
$151M
| $75K | ﹤0.01% |
+15,578
| New | +$71K |
|
|
CHRN
2754
ChronoScale Holdings
CHRN
$3.2B
| $75K | ﹤0.01% |
81
-23
| -22% | -$19.6K |
|
2755
Globalstar
GSAT
$10.7B
| $75K | ﹤0.01% |
3,112
-4,587
| -60% | -$103K |
|
|
ENOC
2756
DELISTED
EnerNOC, Inc.
ENOC
| $75K | ﹤0.01% |
12,460
-13,593
| -52% | -$77.3K |
|
|
ETRM
2757
DELISTED
EnteroMedics Inc.
ETRM
| $75K | ﹤0.01% |
12,936
-508
| -4% | -$3.76K |
|
2758
Globus Maritime Ltd
GLBS
$61.9M
| $74K | ﹤0.01% |
16
-13
| -45% | -$83.4K |
|
2759
Mizuho Financial
MFG
$127B
| $74K | ﹤0.01% |
19,928
-3,249
| -14% | -$12.1K |
|
|
IMGN
2760
DELISTED
Immunogen Inc
IMGN
| $74K | ﹤0.01% |
19,159
-117,994
| -86% | -$344K |
|
|
LEJU
2761
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $74K | ﹤0.01% |
2,144
+1,126
| +111% | +$43.4K |
|
|
IPAS
2762
DELISTED
Ipass Inc Common Stock
IPAS
| $74K | ﹤0.01% |
6,285
+4,107
| +189% | +$56.1K |
|
2763
Plus Therapeutics
PSTV
$26.6M
| – | – |
0
| – | – |
|
|
CBR
2764
DELISTED
CIBER Inc.
CBR
| $73K | ﹤0.01% |
181,336
+141,395
| +354% | +$63.9K |
|
2765
Immunic
IMUX
$190M
| $72K | ﹤0.01% |
+45
| New | +$82.4K |
|
|
JXG
2766
JX Luxventure
JXG
| $72K | ﹤0.01% |
22
+20
| +1,000% | +$61.9K |
|
2767
Coffee Holding Co
JVA
$19.5M
| $71K | ﹤0.01% |
15,319
-6,931
| -31% | -$32.3K |
|
2768
Nomura Holdings
NMR
$28.3B
| $71K | ﹤0.01% |
11,314
-9,896
| -47% | -$63.4K |
|
|
KLDX
2769
DELISTED
KLONDEX MINES LTD
KLDX
| $71K | ﹤0.01% |
18,213
+6,934
| +61% | +$34.9K |
|
|
SPHS
2770
DELISTED
Sophiris Bio, Inc.
SPHS
| $71K | ﹤0.01% |
25,205
-18,435
| -42% | -$50.5K |
|
|
MMT
2771
Aberdeen Multi-Market Income Fund
MMT
$236M
| $70K | ﹤0.01% |
11,366
-14,839
| -57% | -$90.5K |
|
2772
INNOVATE Corp
VATE
$111M
| $70K | ﹤0.01% |
1,127
-1,279
| -53% | -$79.4K |
|
|
MXWL
2773
DELISTED
Maxwell Technologies Inc
MXWL
| $70K | ﹤0.01% |
+12,041
| New | +$61.9K |
|
2774
Amtech Systems
ASYS
$268M
| $69K | ﹤0.01% |
12,455
+1,697
| +16% | +$9.29K |
|
2775
Clear Channel Outdoor Holdings
CCO
$1.23B
| $69K | ﹤0.01% |
+11,379
| New | +$60K |
|
Similar funds
CAM
DL
RBC
TCM
HCM
AL
AT
GA
Virtu KCG Holdings's Q1 2017 Portfolio in Review
As of Q1 2017, Virtu KCG Holdings held 4,266 positions worth $3.61B, down 11% from $4.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Virtu KCG Holdings withdrew a net $605M in Q1 2017, closing 1,190 positions and reducing 1,173 holdings. Its most notable exit was FedEx, an estimated $7.61M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 8.7% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Virtu KCG Holdings opened a new position in SPDR Long Dollar Gold Trust worth $11.3M.
- Virtu KCG Holdings's largest Q1 2017 buy was SPDR Long Dollar Gold Trust: 91,088 shares worth $11.3M.
- Virtu KCG Holdings added most to Berkshire Hathaway Class A in Q1 2017, an estimated $14.3M increase.
- Virtu KCG Holdings's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $71.3M.
- Virtu KCG Holdings fully exited FedEx in Q1 2017, selling an estimated $7.61M.
- Virtu KCG Holdings's ten largest holdings make up 30% of its $3.61B portfolio in Q1 2017.
- Virtu KCG Holdings opened 919 new positions and closed 1,190 in Q1 2017.
- Virtu KCG Holdings's portfolio value fell 11% quarter-over-quarter to $3.61B.
Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.